Inherited colorectal cancer risk variants: from association to biology
遗传性结直肠癌风险变异:从关联到生物学
基本信息
- 批准号:9922218
- 负责人:
- 金额:$ 77.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:11q2312q1319q131q4120p123-Dimensional8q24AgingAllelesApoptosisBiologicalBiological AssayBiologyBiopsyCRISPR/Cas technologyCancer EtiologyCandidate Disease GeneChIP-seqChromosome MappingColonColorectal CancerDNA DamageDNA Sequence AlterationDataData SetDevelopmentEnhancersEpithelialEpitheliumEventFluorescenceFundingFutureGene ExpressionGene TargetingGenesGenetic Enhancer ElementGenetic RiskGenome StabilityGenotypeGoalsGrantGuidelinesH2AFX geneHumanImmunofluorescence ImmunologicImmunohistochemistryIn VitroIncidenceIndividualInheritedInterventionKnock-outLeadLengthMADH7 geneMeasuresMethodsMolecularMorphologyNormal tissue morphologyNucleic Acid Regulatory SequencesOrganoidsPathway interactionsPatientsPhasePhenotypePhosphorylationPlayPopulationPremature aging syndromeProteinsRegulatory ElementRiskRisk FactorsRoleSamplingSignal PathwaySignal TransductionSystemTCF7L2 geneTechnologyTestingTransforming Growth Factor betaTranslatingUlcerative ColitisValidationVariantWorkXp22carcinogenicitycolon cancer cell linecolorectal cancer preventioncolorectal cancer riskcolorectal cancer treatmentcrypt cellgenome sequencinggenome wide association studygenome-wideimprovedinsightknock-downlifetime risknoveloverexpressionprematurepromoterpublic health relevancerisk variantsuccesstelomeretooltranscriptome sequencingtumorwhole genome
项目摘要
DESCRIPTION (provided by applicant): The goal of the proposed study is to discern the functional and biological relevance of colorectal cancer (CRC) risk variants identified through genome wide association studies (GWAS). During the first funding period we established a functional characterization pipeline to investigate the mechanistic basis underlying CRC risk. Using this pipeline we identified functional regulatory elements/enhancers/promoters for 8 GWAS regions and target genes for 8 GWAS regions by eQTL analysis. To keep pace with the rate of discovery of novel GWAS risk variants and to further interrogate the mechanistic and biological relevance of GWAS risk variants we now propose the following Specific Aims. Aim 1: We will build upon the successful molecular characterization pipeline we have developed and identify additional novel functional regulatory regions/enhancers/promoters and target genes from GWAS risk regions through incorporation of fine mapping data from the OncoArray study, genome wide chromatin immunoprecipitation and sequencing (ChIPseq) data from normal colon crypts from 10 healthy subjects, and apply genome wide eQTL analyses using RNA-seq data from >1100 normal colon epithelial biopsies. Aim 2: Using data from Aim 1 we will knock down or over-express candidate risk target genes in normal human 3D colon epithelial organoid cultures using lentiviral systems and examine the effect on morphology, proliferation, apoptosis and common signaling pathways followed by validation in normal tissues by immunohistochemical/fluorescence approaches. We will confirm the correlation between active regulatory elements and target genes following knock out of regulatory elements by CRISPR-Cas9 methods in CRC cell lines followed by RT-qPCR validation. Where no target genes of active regulatory regions have been identified we will identify candidate target genes following knock out of regulatory elements by CRISPR-Cas9 methods in CRC cell lines followed by RNA-Seq eQTL analysis. Finally, in Aim 3: We will test the hypothesis that CRC risk variants lead to a premature aging phenotype in colon crypts. We will determine the correlation between risk variant burden and accumulated DNA mutations in colon crypts. DNA damage will be assessed by measuring histone H2AX phosphorylation, whole genome sequencing and telomere length measured by quantitative PCR. This study will provide insight into the role of genetic risk variants on normal biology of the colon crypt and CRC etiology.
描述(由应用程序提供):拟议的研究的目的是辨别结直肠癌(CRC)风险变体的功能和生物学相关性,这些变体通过基因组广泛的关联研究(GWAS)确定。在第一个资金期间,我们建立了一个功能表征管道,以研究CRC风险的机械基础。使用该管道,我们通过EQTL分析确定了8个GWAS区域的功能调节元件/增强子/启动子和靶基因的8个GWA区域。为了使新型GWAS风险变体的发现率保持空间,并进一步询问GWAS风险变体的机械和生物学相关性,我们现在提出以下特定目标。目的1:我们将基于我们开发的成功分子表征管道,并通过感染OnCoArray研究,基因组宽染色质免疫沉淀和使用10 colon collys的基因范围(CHIPSEQ)数据,并使用10个健康的crage sects,以及使用10个健康的基因 - 以及使用10个健康的crages copls,以及对GWAS风险区域的其他新型调节区/启动子和目标基因进行的靶向基因,并使用10个健康的craneme(Chipseq)数据。来自> 1100个正常结肠上皮活检的数据。 AIM 2:使用AIM 1的数据,我们将使用慢病毒系统在正常人类3D结肠上皮细胞器中击倒或过表达的候选风险靶基因,并检查对免疫组织/荧光验证正常组织对正常组织验证的对形态学,增殖,凋亡和常见信号通路的影响。我们将通过CRC细胞系中的CRISPR-CAS9方法从调节元件中敲出调节元件后,确认主动调节元件与靶基因之间的相关性,然后是RT-QPCR验证。如果尚未确定活跃调控区域的靶基因,我们将通过CRC细胞系中的CRISPR-CAS9方法击倒调节元件后,将鉴定出候选靶基因,然后再进行RNA-SEQ EQTL分析。最后,在AIM 3中:我们将检验以下假设:CRC风险变异会导致结肠隐窝中的过早衰老表型。我们将确定结肠隐窝中的风险变体和累积的DNA突变之间的相关性。 DNA损伤将通过测量组蛋白H2AX磷酸化,整个基因组测序和通过定量PCR测量的端粒长度来评估。这项研究将洞悉遗传风险变异对结肠隐窝和CRC病因的正常生物学的作用。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Race-Specific, DNA Methylation Analysis of Aging in Normal Rectum: Implications for the Biology of Aging and Its Relationship to Rectal Cancer.
- DOI:10.3390/cancers15010045
- 发表时间:2022-12-22
- 期刊:
- 影响因子:5.2
- 作者:
- 通讯作者:
Multi-omic analysis in normal colon organoids highlights MSH4 as a novel marker of defective mismatch repair in Lynch syndrome and microsatellite instability.
- DOI:10.1002/cam4.6048
- 发表时间:2023-06
- 期刊:
- 影响因子:4
- 作者:
- 通讯作者:
Controlling for cellular heterogeneity using single-cell deconvolution of gene expression reveals novel markers of colorectal tumors exhibiting microsatellite instability.
- DOI:10.18632/oncotarget.27935
- 发表时间:2021-04-13
- 期刊:
- 影响因子:0
- 作者:Devall MAM;Casey G
- 通讯作者:Casey G
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.
- DOI:10.1038/srep12372
- 发表时间:2015-08-03
- 期刊:
- 影响因子:4.6
- 作者:Al-Tassan NA;Whiffin N;Hosking FJ;Palles C;Farrington SM;Dobbins SE;Harris R;Gorman M;Tenesa A;Meyer BF;Wakil SM;Kinnersley B;Campbell H;Martin L;Smith CG;Idziaszczyk S;Barclay E;Maughan TS;Kaplan R;Kerr R;Kerr D;Buchanan DD;Win AK;Hopper J;Jenkins M;Lindor NM;Newcomb PA;Gallinger S;Conti D;Schumacher F;Casey G;Dunlop MG;Tomlinson IP;Cheadle JP;Houlston RS
- 通讯作者:Houlston RS
Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.
- DOI:10.1371/journal.pone.0111914
- 发表时间:2014
- 期刊:
- 影响因子:3.7
- 作者:Fortini BK;Tring S;Plummer SJ;Edlund CK;Moreno V;Bresalier RS;Barry EL;Church TR;Figueiredo JC;Casey G
- 通讯作者:Casey G
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRAHAM CASEY其他文献
GRAHAM CASEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRAHAM CASEY', 18)}}的其他基金
Functional Characterization of Glioma GWAS Variants
胶质瘤 GWAS 变异体的功能表征
- 批准号:
9336270 - 财政年份:2016
- 资助金额:
$ 77.11万 - 项目类别:
Functional Characterization of Glioma GWAS Variants
胶质瘤 GWAS 变异体的功能表征
- 批准号:
9743742 - 财政年份:2016
- 资助金额:
$ 77.11万 - 项目类别:
Using functional genomics to inform gene environment interactions for colorectal cancer
使用功能基因组学来了解结直肠癌的基因环境相互作用
- 批准号:
9763541 - 财政年份:2016
- 资助金额:
$ 77.11万 - 项目类别:
Using functional genomics to inform gene environment interactions for colorectal cancer
使用功能基因组学来了解结直肠癌的基因环境相互作用
- 批准号:
9174797 - 财政年份:2016
- 资助金额:
$ 77.11万 - 项目类别:
Using functional genomics to inform gene environment interactions for colorectal cancer
使用功能基因组学来了解结直肠癌的基因环境相互作用
- 批准号:
9357531 - 财政年份:2016
- 资助金额:
$ 77.11万 - 项目类别:
Functional Characterization of Glioma GWAS Variants
胶质瘤 GWAS 变异体的功能表征
- 批准号:
9159686 - 财政年份:2016
- 资助金额:
$ 77.11万 - 项目类别:
Inherited colorectal cancer risk variants: from association to biology
遗传性结直肠癌风险变异:从关联到生物学
- 批准号:
9414978 - 财政年份:2010
- 资助金额:
$ 77.11万 - 项目类别:
相似国自然基金
12q13区域内单纯性先天性心脏病易感基因的鉴定与克隆
- 批准号:30200305
- 批准年份:2002
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Validating novel candidate genes for normal-tension glaucoma
验证正常眼压性青光眼的新候选基因
- 批准号:
10749126 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
CDK4 Inhibitor Therapy: Identification of Biomarkers and Combination Therapies for Liposarcoma
CDK4 抑制剂疗法:脂肪肉瘤生物标志物的鉴定和联合疗法
- 批准号:
10247698 - 财政年份:2018
- 资助金额:
$ 77.11万 - 项目类别:
CDK4 Inhibitor Therapy: Identification of Biomarkers and Combination Therapies for Liposarcoma
CDK4 抑制剂疗法:脂肪肉瘤生物标志物的鉴定和联合疗法
- 批准号:
10468963 - 财政年份:2018
- 资助金额:
$ 77.11万 - 项目类别:
CDK4 Inhibitor Therapy: Identification of Biomarkers and Combination Therapies for Liposarcoma
CDK4 抑制剂疗法:脂肪肉瘤生物标志物的鉴定和联合疗法
- 批准号:
10016097 - 财政年份:2018
- 资助金额:
$ 77.11万 - 项目类别:
Analyses of anti-tumor activities regarding pazopanib in soft tissue sarcoma
帕唑帕尼对软组织肉瘤的抗肿瘤活性分析
- 批准号:
17K10987 - 财政年份:2017
- 资助金额:
$ 77.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)